{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:40:51Z","timestamp":1785872451024,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00134-026-08337-1","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:19:42Z","timestamp":1771316382000},"page":"566-569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vasopressor use in septic shock: separating evidence, practice, and future directions"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-1030","authenticated-orcid":false,"given":"Nicolas","family":"Fage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Asfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"8337_CR1","doi-asserted-by":"crossref","unstructured":"Monnet X, Messina A, Greco M, Bakker J, Aissaoui N, Cecconi M, et al. ESICM guidelines on circulatory shock and hemodynamic monitoring 2025. Intensive Care Med. 2025.","DOI":"10.1007\/s00134-025-08137-z"},{"issue":"11","key":"8337_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181\u20131247","journal-title":"Intensive Care Med"},{"issue":"6","key":"8337_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/00024382-200212000-00002","volume":"18","author":"H Ensinger","year":"2002","unstructured":"Ensinger H, Geisser W, Brinkmann A, Wachter U, Vogt J, Radermacher P et al (2002) Metabolic effects of norepinephrine and dobutamine in healthy volunteers. Shock d\u00e9c 18(6):495\u2013500","journal-title":"Shock d\u00e9c"},{"key":"8337_CR4","first-page":"84","volume":"17","author":"WE Clutter","year":"1980","unstructured":"Clutter WE, Cryer PE (1980) Plasma dose-response studies with noradrenaline and adrenaline in man. Prog Biochem Pharmacol 17:84\u201389","journal-title":"Prog Biochem Pharmacol"},{"issue":"9","key":"8337_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358(9):877\u2013887","journal-title":"N Engl J Med"},{"issue":"5","key":"8337_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH Randomized Clinical Trial. JAMA 316(5):509\u2013518","journal-title":"JAMA"},{"issue":"12","key":"8337_CR7","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/CCM.0000000000004023","volume":"47","author":"LA Hajjar","year":"2019","unstructured":"Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G et al (2019) Vasopressin versus norepinephrine for the management of septic shock in cancer patients: The VANCS II Randomized Clinical Trial. Crit Care Med d\u00e9c 47(12):1743\u20131750","journal-title":"Crit Care Med d\u00e9c"},{"issue":"5","key":"8337_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377(5):419\u2013430","journal-title":"N Engl J Med"},{"issue":"1","key":"8337_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","volume":"27","author":"PM Wieruszewski","year":"2023","unstructured":"Wieruszewski PM, Bellomo R, Busse LW, Ham KR, Zarbock A, Khanna AK et al (2023) Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial. Crit Care 27(1):175","journal-title":"Crit Care"},{"issue":"9","key":"8337_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S et al (2018) Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 378(9):809\u2013818","journal-title":"N Engl J Med"},{"issue":"6","key":"8337_CR11","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","volume":"31","author":"T Sharshar","year":"2003","unstructured":"Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31(6):1752","journal-title":"Crit Care Med"},{"issue":"5","key":"8337_CR12","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","volume":"95","author":"DW Landry","year":"1997","unstructured":"Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, D\u2019Alessandro D et al (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95(5):1122\u20131125","journal-title":"Circulation"},{"issue":"1","key":"8337_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13054-025-05311-z","volume":"29","author":"DE Leisman","year":"2025","unstructured":"Leisman DE, Wieruszewski PM, Busse LW, Chawla LS, Hibbert KA, Handisides DR et al (2025) An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock. Crit Care 29(1):81","journal-title":"Crit Care"},{"key":"8337_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","volume":"24","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Wunderink RG, Szerlip H, English SW, Busse LW, Deane AM et al (2020) Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock. Crit Care 24:43","journal-title":"Crit Care"},{"issue":"1","key":"8337_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13054-024-04910-6","volume":"28","author":"DE Leisman","year":"2024","unstructured":"Leisman DE, Handisides DR, Busse LW, Chappell MC, Chawla LS, Filbin MR et al (2024) ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock. Crit Care 28(1):130","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08337-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:34:06Z","timestamp":1774877646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08337-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["8337"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08337-1","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MSC is a Section Editor for Intensive Care Medicine. She has not taken part in the review or selection process of this article. Other authors declare that they have no competing interest related to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}